Dysmetabolic iron overload syndrome (DIOS)

被引:61
|
作者
Deugnier, Yves [1 ,2 ,3 ]
Bardou-Jacquet, Edouard [1 ,2 ,3 ]
Laine, Fabrice [1 ,3 ]
机构
[1] CHU Rennes, Hop Pontchaillou, Ctr Reference Surcharges Genet Fer, Serv Malad Foie, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France
[2] Univ Rennes 1, Fac Med, F-35034 Rennes, France
[3] Hop Pontchaillou, INSERM, CIC1414, F-35033 Rennes, France
来源
PRESSE MEDICALE | 2017年 / 46卷 / 12期
关键词
NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE SYNDROME; SERUM FERRITIN; ADIPOSE-TISSUE; METABOLIC SYNDROME; TRANSFERRIN SATURATION; PHENOTYPIC-EXPRESSION; DISEASE; HEPCIDIN; HYPERFERRITINEMIA;
D O I
10.1016/j.lpm.2017.05.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.
引用
收藏
页码:E306 / E311
页数:6
相关论文
共 50 条
  • [11] Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome
    Vetro, Calogero
    Rosso, Rosamaria
    Palmucci, Stefano
    Russello, Maurizio
    Colletta, Grazia
    Romeo, Maria Anna
    Ximenes, Benedetta
    Romano, Alessandra
    Palumbo, Giuseppe Alberto
    Di Raimondo, Francesco
    JOURNAL OF CLINICAL APHERESIS, 2016, 31 (05) : 443 - 447
  • [12] Non-invasive methods for iron overload evaluation in dysmetabolic patients
    Branissoa, Paula Pessin Fabrega
    Oliveira, Claudia Pinto Marques Souza de
    Filho, Hilton Muniz Leao
    Lima, Fabiana Roberto
    Santose, Aritania Sousa
    Mancini, Marcio Correa
    de Melo, Maria Edna
    Carrilho, Flair Jose
    Rocha, Manoel de Souza
    Clark, Paul
    Branissok, Henrique Jose Pereira
    Cercato, Cintia
    ANNALS OF HEPATOLOGY, 2022, 27 (04)
  • [13] Metabolic and Hepatic Effects of Bloodletting in Dysmetabolic Iron Overload Syndrome: A Randomized Controlled Study in 274 Patients
    Laine, Fabrice
    Ruivard, Marc
    Loustaud-Ratti, Veronique
    Bonnet, Fabrice
    Cales, Paul
    Edouard, Bardou-Jacquet -
    Sacher-Huvelin, Sylvie
    Causse, Xavier
    Beusnel, Christine
    Renault, Alain
    Bellissant, Eric
    Deugnier, Yves
    HEPATOLOGY, 2017, 65 (02) : 465 - 474
  • [14] Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin
    Luke Y. Chen
    Silvia D. Chang
    Gayatri M. Sreenivasan
    Peter W. Tsang
    Raewyn C. Broady
    Charles H. Li
    Leslie N. Zypchen
    Annals of Hematology, 2011, 90 : 139 - 143
  • [15] Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin
    Chen, Luke Y.
    Chang, Silvia D.
    Sreenivasan, Gayatri M.
    Tsang, Peter W.
    Broady, Raewyn C.
    Li, Charles H.
    Zypchen, Leslie N.
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 139 - 143
  • [16] Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome
    Bardou-Jacquet, Edouard
    Laine, Fabrice
    Morcet, Jeff
    Perrin, Michele
    Guyader, Dominique
    Deugnier, Yves
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (04) : 418 - 421
  • [17] Both Hepatic and Body Iron Stores Are Increased in Dysmetabolic Iron Overload Syndrome. A Case-Control Study
    Jezequel, Caroline
    Laine, Fabrice
    Laviolle, Bruno
    Kiani, Anita
    Bardou-Jacquet, Edouard
    Deugnier, Yves
    PLOS ONE, 2015, 10 (06):
  • [18] Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
    Barisani, Donatella
    Pelucchi, Sara
    Mariani, Raffaella
    Galimberti, Stefania
    Trombini, Paola
    Fumagalli, Daniela
    Meneveri, Raffaella
    Nemeth, Elizabeta
    Ganz, Tomas
    Piperno, Alberto
    JOURNAL OF HEPATOLOGY, 2008, 49 (01) : 123 - 133
  • [19] Eicosanoids and Oxylipin Signature in Hereditary Hemochromatosis Patients Are Similar to Dysmetabolic Iron Overload Syndrome Patients but Are Impacted by Dietary Iron Absorption
    Lobbes, Herve
    Dalle, Celine
    Pereira, Bruno
    Ruivard, Marc
    Mazur, Andrzej
    Gladine, Cecile
    ANNALS OF NUTRITION AND METABOLISM, 2024, 80 (03) : 117 - 127
  • [20] Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: An update
    Ruivard, M.
    REVUE DE MEDECINE INTERNE, 2009, 30 (01): : 35 - 42